User: Guest  Login
Document type:
journal article 
Author(s):
Protzer, U; Abken, H 
Title:
Can engineered "designer" T cells outsmart chronic hepatitis B? 
Abstract:
More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary. While a vaccine is available and new antiviral drugs are being developed, elimination of persistently infected cells is still a major issue. Recent efforts in adoptive cell therapy are experimentally exploring immunotherapeutic elimination of HBV-infected cells by means of a biological attack...    »
 
Journal title abbreviation:
Hepat Res Treat 
Year:
2010 
Journal volume:
2010 
Pages contribution:
901216 
Language:
eng 
Print-ISSN:
2090-1364 
TUM Institution:
Institut für Virologie